Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Stockholders Equity of $3.18 billion for fiscal year 2025.
WEST PHARMACEUTICAL SERVICES INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $3.18B | +18.4% |
| 2024 | $2.68B | -6.9% |
| 2023 | $2.88B | +7.3% |
| 2022 | $2.68B | +15.0% |
| 2021 | $2.34B | +25.9% |
| 2020 | $1.85B | +17.9% |
| 2019 | $1.57B | +12.7% |
| 2018 | $1.40B | +9.1% |
| 2017 | $1.28B | +14.5% |
| 2016 | $1.12B | +9.1% |
| 2015 | $1.02B | +7.0% |
| 2014 | $956.90M | +5.6% |
| 2013 | $906.40M | +24.4% |
| 2012 | $728.90M | +11.3% |
| 2011 | $654.90M | +4.7% |
| 2010 | $625.70M | +8.0% |
| 2009 | $579.10M | +18.9% |
| 2008 | $487.10M | -0.8% |
| 2007 | $490.90M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.05B | +10.9% | +4.2% |
| June 30, 2025 | $2.93B | +13.7% | +9.2% |
| March 31, 2025 | $2.68B | +0.1% | +0.0% |
| December 31, 2024 | $2.68B | -6.9% | -2.5% |
| September 30, 2024 | $2.75B | -4.0% | +6.8% |
| June 30, 2024 | $2.58B | -6.2% | -3.9% |
| March 31, 2024 | $2.68B | -3.4% | -7.0% |
| December 31, 2023 | $2.88B | +7.3% | +0.4% |
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +18.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, WEST PHARMACEUTICAL SERVICES INC’s stockholders equity has grown by 547.0% (from $490.90 million to $3.18 billion).
- The most recent figure is from WEST PHARMACEUTICAL SERVICES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: